| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $815.8M | +3.5% | +25.9% |
| Cost of Revenue | $191.3M | +3.5% | +28.8% |
| Gross Profit | $624.5M | +3.5% | +25.0% |
| R&D Expense | $229.1M | +14.3% | +34.1% |
| SG&A Expense | $78.2M | +19.1% | +28.6% |
| Operating Income | -$51.8M | -42.4% | -29.0% |
| Pre-tax Income | -$21.3M | -154.3% | -28.8% |
| Income Tax | $13.0M | +301.5% | +247.7% |
| Net Income | -$34.3M | -195.4% | -344.2% |
| EPS (Basic) | -$0.21 | -200.0% | -320.0% |
| EPS (Diluted) | -$0.21 | -200.0% | -320.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.20B | -10.1% | -31.6% |
| Accounts Receivable | $551.8M | +4.0% | +7.3% |
| Current Assets | $4.45B | +5.8% | +21.4% |
| Total Assets | $6.75B | +3.9% | +34.9% |
| Current Liabilities | $2.34B | +1.5% | -23.2% |
| Total Liabilities | $4.56B |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $652.4M | +45.5% | — |
| Capital Expenditures | $35.1M | +102.6% | — |
| Investing Cash Flow | -$1.86B | -24.0% | — |
| Financing Cash Flow | $24.5M | +689.5% | — |
| Free Cash Flow | $617.3M | +43.2% | — |
| +34.1% |
| Stockholders' Equity | $2.20B | +10.8% | +36.6% |